Provenge (Dendreon Corporation)
Welcome to the PulseAid listing for the Provenge drug offered from Dendreon Corporation. This Autologous Cellular Immunotherapy [EPC],Cell-mediated Immunity [PE],Cells, Cultured, Autologous [Chemical/Ingredient],Peripheral Blood Mononuclear Cells [Chemical/Ingredient] pharmaceutical is classified as a CELLULAR THERAPY. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same CELLULAR THERAPY drug type category.
| LABELER NAME / MANUFACTURER: | Dendreon Corporation |
| NON-PROPRIETARY NAME: | Sipuleucel-T |
| SUBSTANCE NAME: | SIPULEUCEL-T |
| TYPE: | CELLULAR THERAPY |
| PHARMA CLASS: | Autologous Cellular Immunotherapy [EPC],Cell-mediated Immunity [PE],Cells, Cultured, Autologous [Chemical/Ingredient],Peripheral Blood Mononuclear Cells [Chemical/Ingredient] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2010-04-29 |
| END MARKETING DATE: | 0000-00-00 |
Provenge CELLULAR THERAPY Details:
| Item Description | Provenge from Dendreon Corporation |
| LABELER NAME: | Dendreon Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50000000(1-Jan) |
| START MARKETING DATE: | 2010-04-29 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 30237-8900_1574a6a0-a77a-43bd-9440-314f62ecb391 |
| PRODUCT NDC: | 30237-8900 |
| APPLICATION NUMBER: | BLA125197 |
Other SIPULEUCEL-T Pharmaceutical Manufacturers / Labelers:
